Free Trial

Taysha Gene Therapies (TSHA) News Today

Taysha Gene Therapies logo
$2.61 -0.14 (-5.09%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$2.58 -0.02 (-0.96%)
As of 07:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TSHA Latest News

Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Recommendation of "Buy" from Brokerages
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) have earned an average recommendation of "Buy" from the seven research firms that are currently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 12 mont
Taysha Gene Therapies, Inc. stock logo
Rafferty Asset Management LLC Takes $436,000 Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Rafferty Asset Management LLC bought a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 252,257 shares of the company's stock, valued at
Taysha Gene Therapies, Inc. stock logo
FY2025 EPS Estimates for TSHA Increased by Cantor Fitzgerald
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) - Cantor Fitzgerald lifted their FY2025 EPS estimates for Taysha Gene Therapies in a note issued to investors on Monday, May 19th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings per share of ($0.36) f
Cantor Fitzgerald Has Positive View of TSHA FY2025 Earnings
Taysha Gene Therapies, Inc. stock logo
VR Adviser LLC Sells 5,774,820 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
VR Adviser LLC reduced its position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 64.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,225,180 shares of the company's stock after
Taysha Gene Therapies, Inc. stock logo
RTW Investments LP Has $15 Million Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
RTW Investments LP cut its stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 42.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,672,630 shares of the company's stock after selling
Q1 2025 Taysha Gene Therapies Inc Earnings Call
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Bought by Octagon Capital Advisors LP
Octagon Capital Advisors LP grew its holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 128.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,450,000 shares of the company's stock after pu
Taysha Gene Therapies, Inc. stock logo
Granahan Investment Management LLC Buys 496,482 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Granahan Investment Management LLC lifted its position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 43.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,636,381 shares of the company's stock after purcha
Taysha Gene Therapies, Inc. stock logo
DAFNA Capital Management LLC Makes New $904,000 Investment in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
DAFNA Capital Management LLC bought a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 522,500 shares of the company's
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies (TSHA) to Release Quarterly Earnings on Tuesday
Taysha Gene Therapies (NASDAQ:TSHA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-taysha-gene-therapies-inc-stock/)
Taysha Gene Therapies, Inc. stock logo
Marshall Wace LLP Lowers Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Marshall Wace LLP trimmed its holdings in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 71.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 138,111 shares of the company
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 9.3% - What's Next?
Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 9.3% - What's Next?
Taysha Gene Therapies, Inc. stock logo
Acuta Capital Partners LLC Cuts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Acuta Capital Partners LLC cut its holdings in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 58.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 884,244 shares of
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of "Buy" from Analysts
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has received an average rating of "Buy" from the eight ratings firms that are presently covering the stock, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation. The average twelve-month price objecti
Taysha Gene Therapies, Inc. stock logo
Adage Capital Partners GP L.L.C. Makes New $8.65 Million Investment in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Adage Capital Partners GP L.L.C. acquired a new position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,000,000 shares of t
Taysha Gene Therapies, Inc. stock logo
JMP Securities Reaffirms "Market Outperform" Rating for Taysha Gene Therapies (NASDAQ:TSHA)
JMP Securities reiterated a "market outperform" rating and issued a $5.00 target price on shares of Taysha Gene Therapies in a report on Monday.
Taysha Gene Therapies, Inc. stock logo
Cantor Fitzgerald Reiterates "Overweight" Rating for Taysha Gene Therapies (NASDAQ:TSHA)
Cantor Fitzgerald reissued an "overweight" rating and set a $7.00 target price on shares of Taysha Gene Therapies in a research note on Monday.
Taysha Gene Therapies, Inc. stock logo
Renaissance Technologies LLC Makes New $1.52 Million Investment in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Renaissance Technologies LLC purchased a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 878,448 shares of the company's stock, valued at approxi
Taysha Gene Therapies, Inc. stock logo
Avoro Capital Advisors LLC Buys 1,349,999 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Avoro Capital Advisors LLC increased its stake in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 7.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 19,999,999 shares of the company's stock after acquiring an add
Taysha Gene Therapies, Inc. stock logo
B Group Inc. Buys Shares of 965,556 Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
B Group Inc. purchased a new position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 965,556 shares of the company's stock, valued at appr
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered its position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 11.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,643,755 shares of the company's stock after
Taysha Gene Therapies, Inc. stock logo
Vanguard Group Inc. Raises Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Vanguard Group Inc. raised its holdings in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) by 7.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,906,764 shares of the company's stock after acquiring
Taysha Gene Therapies, Inc. stock logo
Norges Bank Takes $2.53 Million Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Norges Bank bought a new position in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,461,120 shares of the company's stock, valued at approximately $2,528,000. Norges
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Analysts
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) have received an average recommendation of "Buy" from the eight analysts that are presently covering the firm, MarketBeat reports. Eight research analysts have rated the stock with a buy rating. The average 12 month price target
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Recommendation of "Buy" from Analysts
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) have been assigned a consensus recommendation of "Buy" from the eight research firms that are presently covering the firm, Marketbeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies (TSHA) to Release Earnings on Tuesday
Taysha Gene Therapies (NASDAQ:TSHA) will be releasing earnings before the market opens on Tuesday, March 18, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=667936)
Taysha Gene Therapies, Inc. stock logo
TSHA FY2025 EPS Forecast Raised by Cantor Fitzgerald
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) - Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of Taysha Gene Therapies in a research report issued on Thursday, February 27th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will p
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies (NASDAQ:TSHA) Given "Buy" Rating at Needham & Company LLC
Needham & Company LLC reissued a "buy" rating and issued a $6.00 price objective on shares of Taysha Gene Therapies in a research note on Thursday.
Truist Financial Keeps Their Buy Rating on Taysha Gene Therapies (TSHA)
Taysha Gene Therapies, Inc. stock logo
Taysha Gene Therapies (NASDAQ:TSHA) Receives "Buy" Rating from Chardan Capital
Chardan Capital reaffirmed a "buy" rating and issued a $7.00 price target on shares of Taysha Gene Therapies in a research note on Wednesday.
Q4 2024 Taysha Gene Therapies Inc Earnings Call
Get Taysha Gene Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSHA and its competitors with MarketBeat's FREE daily newsletter.

TSHA Media Mentions By Week

TSHA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TSHA
News Sentiment

1.23

1.03

Average
Medical
News Sentiment

TSHA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TSHA Articles
This Week

10

3

TSHA Articles
Average Week

Get Taysha Gene Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for TSHA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TSHA) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners